New heart valves show promise in 5-Year Follow-Up study

NCT ID NCT05055089

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 172 patients who received either a new-generation biological aortic valve or a traditional one during heart surgery. Researchers tracked survival and valve function over five years to see how the newer valves compare. The goal is to provide real-world data on these newer devices.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

new-generation biological aortic valve (rapid deployment or sutureless bioprosthesis)

What this could lead to

If successful, this study could provide evidence that newer aortic valves perform as well or better than traditional ones, potentially guiding future surgical choices.

What could go wrong

This is an observational, retrospective study with a moderate sample size, so results may not be definitive or widely generalizable. No new treatment is being tested.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Amiens Nord

    Amiens, 80054, France